Canmab 440mg Injection is a monoclonal antibody. It works by blocking the actions of certain cellular proteins (HER2) that triggers cancer cell formation. It also blocks various downstream cell signalling pathways that triggers cancer growth within the body. As a result, it reduces cancer formation and prevents its further growth within the body.
Public Event
10 May - 31 Dec
10 May 02:30 PM to 31 Dec 11:00 PM
Canmab 440mg Injection contains Trastuzumab which belongs to the group of medicines called Anticancer drugs. It is used to treat breast cancer and stomach cancer.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek